• Entecavir and HBV Resistance: Reading the Evidence

  2026-10-05

  Entecavir is a potent HBV polymerase inhibitor, but resistance risk depends strongly on prior nucleos(t)ide exposure. This evidence-focused analysis explains what the 2024 meta-analysis reveals, where its estimates are robust, and where clinical and surveillance gaps remain.

• LNP mRNA Vaccine Design for RSV: Study Findings

  2026-10-05

  A 2025 Journal of Pharmaceutical Investigation study developed and evaluated a lipid nanoparticle system for intramuscular delivery of mRNA encoding a conserved region of the RSV G glycoprotein. The preclinical formulation showed strong expression, antibody and T-cell responses, and complete protection in the reported RSV challenge model, while its relevance beyond this antigen, formulation, and animal setting remains to be established.

• Sulfachloropyridazine in E. tenella Cecal Omics

  2026-10-04

  The 2022 Microbial Pathogenesis study combined 16S rRNA gene sequencing with LC-MS/MS metabolomics to examine how Eimeria tenella infection and treatment reshape the chicken cecal environment. Its findings distinguish an ethanamizuril-associated microbiota profile, reduced Escherichia-Shigella after sulfachlorpyridazine treatment, and comparatively limited effects from the low-dose combination, while emphasizing that these are context-specific associations rather than proof of mechanism.

• Isorhamnetin: PI3K/Akt Evidence Guide

  2026-10-03

  Isorhamnetin is a flavonoid compound linked to PI3K/Akt activation in a preclinical porcine oocyte study. The evidence supports research into oxidative stress, apoptosis, mitochondrial regulation, and endoplasmic reticulum stress, but it does not establish human fertility efficacy or a universal pathway effect.

• 293T Cells for CRISPR Workflow Design

  2026-10-02

  293T Cells provide a human cell-based platform for transient expression, reporter testing, and genome-engineering workflows, but the cells do not perform CRISPR editing without externally supplied editing components. Their biological rationale derives from the HEK293 lineage and SV40 large T-antigen expression, while multiplex CRISPR applications require independent guide, nuclease, and control design.

• Dutasteride Workflows for Prostate Research

  2026-10-01

  Dutasteride supports mechanism-driven studies that connect dual 5-alpha-reductase inhibition with DHT depletion, growth control, and apoptosis readouts. This workflow emphasizes solvent discipline, orthogonal target-engagement assays, and a carefully bounded comparison with metabolite–immune signaling research.

• 7-AAD Cell Viability Assay Kit for CAR-T Readouts

  2026-10-01

  The 7-AAD Cell Viability Assay Kit provides a red-fluorescence membrane-integrity readout for necrotic and late apoptotic cells. Its compatibility with flow cytometry, fluorescence microscopy, and multiplex markers makes the 7-amino actinomycin D assay useful for evaluating cytotoxicity and fratricide in CD38 CAR-T research.

• Resiquimod (R-848) for Ablation Immunotherapy

  2026-09-30

  Resiquimod (R-848) connects TLR7/8 activation with practical assays for cytokine release, dendritic-cell maturation, macrophage polarization, and localized tumor-ablative immunotherapy. This guide translates a thermal-protective hydrogel study into controlled workflows that distinguish compound activity from heat injury, formulation effects, and delivery kinetics.

• HyperScribe™ Cy5 RNA Labeling Kit: Lab Guide

  2026-09-30

  Learn how SKU K1062 can support reproducible fluorescent RNA probe synthesis when viability, proliferation, or cytotoxicity assays require mechanistic transcript-level context. This scenario-based guide covers probe design, T7 transcription, Cy5-UTP optimization, interpretation, and practical product selection.

• Inonotus obliquus Polysaccharide in Rheumatoid Arthritis

  2026-09-29

  This study combines network pharmacology with cell-based and collagen-induced arthritis experiments to investigate how Inonotus obliquus polysaccharide (IOP) affects rheumatoid arthritis. The findings connect IOP with suppression of NF-κB and NLRP3 inflammasome signaling, reduced inflammatory activity, and inhibition of rheumatoid synovial fibroblast-like behavior.

• 293T Cells for Multiplex CRISPR Assay Design

  2026-09-29

  293T Cells provide a practical platform for testing delivery, guide combinations, and readouts in multiplex CRISPR workflows. This article explains how to use them as an assay-calibration system while recognizing the biological limits that separate transfection feasibility from disease-relevant validation.

• Betaine Hydrochloride for Mechanistic Assays

  2026-09-28

  Explore how Betaine hydrochloride can improve assay design for metabolic enzymes, proteases, cell culture, and molecular biology. This article connects practical reagent control with mechanistic lessons from a 2025 oridonin study of inflammation-driven esophageal cancer.

• Bacitracin (B1670): Practical Research Guide

  2026-09-28

  Bacitracin is a peptide antibiotic for controlled in-vitro studies of bacterial growth and cell-wall or peptidoglycan synthesis disruption. Use it in research workflows with appropriate vehicle and growth controls; it is not intended for diagnostic, clinical, or medical use.

• Baricitinib and Spatial Inflammation in PSC

  2026-09-27

  Spatial proteomics is changing how researchers interpret cytokine activity in diseased tissue. This article examines how Baricitinib (LY3009104) can help test JAK1/2-dependent signaling downstream of IL-6, while distinguishing mechanistic hypotheses from evidence in human primary sclerosing cholangitis and preclinical arthritis models.

• HyperPFU™ High-Fidelity DNA Polymerase PCR Guide

  2026-09-26

  HyperPFU™ high-fidelity DNA polymerase is designed for accurate PCR amplification of long, GC-rich, or otherwise difficult templates, producing blunt-ended amplicons for cloning and sequencing workflows. It is not the right choice when the PCR product must carry 3′-A overhangs or when a workflow specifically requires sticky ends.

8586 records 1/573 page Next 12345 下5页 Last page